These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12549967)

  • 1. Ballism associated with bupropion use.
    de Graaf L; Admiraal P; van Puijenbroek EP
    Ann Pharmacother; 2003 Feb; 37(2):302-3. PubMed ID: 12549967
    [No Abstract]   [Full Text] [Related]  

  • 2. Mixed-type (limb-truncal and orofacial) bupropion-associated dyskinesia.
    Ferentinos P; Christodoulou C; Rizos E; Douzenis A; Lykouras L
    J Clin Psychopharmacol; 2010 Oct; 30(5):644-6. PubMed ID: 20841971
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of clozapine-associated tardive dyskinesia.
    Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744
    [No Abstract]   [Full Text] [Related]  

  • 4. Mirtazapine in bupropion-induced dyskinesias: a case report.
    Kohen I; Sarcevic A
    Mov Disord; 2006 Apr; 21(4):584-5. PubMed ID: 16511872
    [No Abstract]   [Full Text] [Related]  

  • 5. Falling backward in two elderly patients taking bupropion.
    Szuba MP; Leuchter AF
    J Clin Psychiatry; 1992 May; 53(5):157-9. PubMed ID: 1592841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine in tardive dyskinesia: observations from human and animal model studies.
    Tamminga CA; Thaker GK; Moran M; Kakigi T; Gao XM
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():102-6. PubMed ID: 7961550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment and treatment of drug-induced tremor.
    Goetz CG; Dysken MW; Klawans HL
    J Clin Psychiatry; 1980 Sep; 41(9):310-5. PubMed ID: 7410325
    [No Abstract]   [Full Text] [Related]  

  • 8. Amantadine in Tourette syndrome.
    Borison RL; Davis JM
    Curr Psychiatr Ther; 1983; 22():127-30. PubMed ID: 6587960
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of cannabinoid CB1 receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys.
    Madsen MV; Peacock LP; Werge T; Andersen MB; Andreasen JT
    Neuropharmacology; 2011; 60(2-3):418-22. PubMed ID: 21029743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment on Nasrallah et al: lower mortality in geriatric patients receiving risperidone and olanzapine versus haloperidol.
    Blazer DG
    Am J Geriatr Psychiatry; 2004; 12(6):658-9; author reply 659-60. PubMed ID: 15545335
    [No Abstract]   [Full Text] [Related]  

  • 11. Tardive dyskinesia presenting as gastrointestinal disorder.
    Goldberg RJ; Morris PL; Lidofsky S
    J Clin Psychiatry; 1990 Jun; 51(6):253-4. PubMed ID: 1971823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic relationship of antisaccade and dyskinesia in schizophrenic patients.
    Cassady SL; Thaker GK; Tamminga CA
    Psychopharmacol Bull; 1993; 29(2):235-40. PubMed ID: 8290671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An animal model to study the molecular basis of tardive dyskinesia.
    Bishnoi M; Boparai RK
    Methods Mol Biol; 2012; 829():193-201. PubMed ID: 22231815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of metoclopramide and haloperidol on tardive dyskinesia [proceedings].
    Bateman DN; Dutta DK; McClelland HA; Rawlins MD
    Br J Pharmacol; 1979 Jul; 66(3):475P-476P. PubMed ID: 526754
    [No Abstract]   [Full Text] [Related]  

  • 15. [Three cases of lingual ballistic movement followed by a rigid-dystonic state of the tongue].
    Horikawa H; Konagaya M; Mano Y; Takayanagi T
    Rinsho Shinkeigaku; 1985 Jun; 25(6):653-8. PubMed ID: 4053459
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of bupropion alone and with haloperidol in schizo-affective disorder, depressed type.
    Goode DJ; Manning AA
    J Clin Psychiatry; 1983 Jul; 44(7):253-5. PubMed ID: 6408068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anandamide attenuates haloperidol-induced vacuous chewing movements in rats.
    Röpke J; Busanello A; Leal CQ; de Moraes Reis E; de Freitas CM; Villarinho JG; Figueira FH; Mello CF; Ferreira J; Fachinetto R
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():195-9. PubMed ID: 24747871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin in treatment of tardive dyskinetic syndrome.
    Truong DD; Hermanowicz N; Rontal M
    J Clin Psychopharmacol; 1990 Dec; 10(6):438-9. PubMed ID: 2286715
    [No Abstract]   [Full Text] [Related]  

  • 19. Life-threatening tardive dyskinesia.
    Chiu HF; Chung DW; Wing YK; Wong CK
    Br J Clin Pract; 1996; 50(3):175-6. PubMed ID: 8733342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug therapy of tardive dyskinesia.
    Kobayashi RM
    N Engl J Med; 1977 Feb; 296(5):257-60. PubMed ID: 12469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.